446 related articles for article (PubMed ID: 16425360)
1. Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3.
Abbas Z; Moatter T; Hussainy A; Jafri W
World J Gastroenterol; 2005 Nov; 11(42):6656-61. PubMed ID: 16425360
[TBL] [Abstract][Full Text] [Related]
2. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
[TBL] [Abstract][Full Text] [Related]
3. Impact of the IL-18 gene polymorphism in response to antiviral therapy in chronic HCV genotype 4 patients.
Mandour M; Nemr N; Kishk R; Ahmed E
Rev Soc Bras Med Trop; 2014; 47(2):137-42. PubMed ID: 24861285
[TBL] [Abstract][Full Text] [Related]
4. Association of SNPs in interferon receptor genes in chronic hepatitis C with response to combined therapy of interferon and ribavirin.
Heidari Z; Shahzamani K; Ghanbari R; Tahamsebifar A
Acta Med Iran; 2014; 52(10):740-7. PubMed ID: 25369007
[TBL] [Abstract][Full Text] [Related]
5. Effect of interleukin-10 gene promoter polymorphisms -1082 G/A and -592 C/A on response to therapy in children and adolescents with chronic hepatitis C virus infection.
El-Karaksy HM; Sharaf SA; Mandour IA; Mogahed EA; Rady NH; El-Mougy FA
Hum Immunol; 2016 Dec; 77(12):1248-1253. PubMed ID: 27660094
[TBL] [Abstract][Full Text] [Related]
6. Cytokine polymorphisms and genotypic susceptibility of HCV infection in ribavirin response to peg interferon.
Trop Biomed; 2023 Sep; 40(3):331-336. PubMed ID: 37897166
[TBL] [Abstract][Full Text] [Related]
7. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein receptor genetic polymorphism in chronic hepatitis C virus Egyptian patients affects treatment response.
Naga M; Amin M; Algendy D; Elbadry A; Fawzi M; Foda A; Esmat S; Sabry D; Rashed L; Gabal S; Kamal M
World J Gastroenterol; 2015 Oct; 21(39):11141-51. PubMed ID: 26494968
[TBL] [Abstract][Full Text] [Related]
9. Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirin.
Perrella A; Sbreglia C; Atripaldi L; Esposito C; D'Antonio A; Perrella O
Scand J Gastroenterol; 2010; 45(2):250-5. PubMed ID: 19968615
[TBL] [Abstract][Full Text] [Related]
10. Role of Th1/Th2 cytokines in serum on the pathogenesis of chronic hepatitis C and the outcome of interferon therapy.
Zhang L; Hao CQ; Miao L; Dou XG
Genet Mol Res; 2014 Nov; 13(4):9747-55. PubMed ID: 25501184
[TBL] [Abstract][Full Text] [Related]
11. Rapid virological response assessment by Abbott RealTime hepatitis C virus assay for predicting sustained virological responses in patients with hepatitis C virus genotype 1 treated with pegylated-interferon and ribavirin.
Su PY; Yen HH; Hsu YC; Wu SS; Kor CT; Su WW
Kaohsiung J Med Sci; 2016 Jul; 32(7):381-6. PubMed ID: 27450028
[TBL] [Abstract][Full Text] [Related]
12. An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C.
Andriulli A; Nardi A; Di Marco V; Ippolito AM; Gavrila C; Aghemo A; Di Paolo D; Squadrito G; Grassi E; Calvaruso V; Valvano MR; Brancaccio G; Craxi A; Angelico M;
Dig Liver Dis; 2014 Sep; 46(9):818-25. PubMed ID: 24953209
[TBL] [Abstract][Full Text] [Related]
13. Secreted Phosphoprotein 1 Promoter Genetic Variants Are Associated with the Response to Pegylated Interferon α Plus Ribavirin Combination Therapy in Egyptian Patients with Chronic Hepatitis C Virus Infection.
Ali FT; Ali MA; Elgizawy MM; Elsawy AM
Gut Liver; 2015 Jul; 9(4):516-24. PubMed ID: 25717047
[TBL] [Abstract][Full Text] [Related]
14. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.
Naito M; Matsui A; Inao M; Nagoshi S; Nagano M; Ito N; Egashira T; Hashimoto M; Mishiro S; Mochida S; Fujiwara K
J Gastroenterol; 2005 Apr; 40(4):381-8. PubMed ID: 15868370
[TBL] [Abstract][Full Text] [Related]
15. Association of TNF-alpha (-308 A/G) and IFN-gamma (+874 A/T) gene polymorphisms in response to spontaneous and treatment induced viral clearance in HCV infected multitransfused thalassemic patients.
Biswas A; Gupta N; Gupta D; Datta A; Firdaus R; Chowdhury P; Bhattacharyya M; Sadhukhan PC
Cytokine; 2018 Jun; 106():148-153. PubMed ID: 29196132
[TBL] [Abstract][Full Text] [Related]
16. Chronic hepatitis C. Genotypes and response to anti-viral therapy among Saudi patients.
Al-Traif I; Handoo FA; Al-Jumah A; Al-Nasser M
Saudi Med J; 2004 Dec; 25(12):1935-8. PubMed ID: 15711670
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C Viral Kinetic Changes in a Retrospective Cohort Study of Chronic Hepatitis C Virus Egyptian Patients on Pegylated Interferon and Ribavirin Therapy.
Esmat GE; Al Akel W; Abdel Aziz RA; Al Sayed Taha A; Sabry D; Rashed LA; Mostafa A; El Kazaz AY; Ahmed SH
J Interferon Cytokine Res; 2016 Mar; 36(3):149-58. PubMed ID: 26982165
[TBL] [Abstract][Full Text] [Related]
18. Dual role of IL-12 in the therapeutic efficacy or failure during combined PEG-Interferon-α2A and ribavirin therapy in patients with chronic hepatitis C.
Araújo AR; Peruhype-Magalhães V; Coelho-dos-Reis JG; Chaves LP; de Lima TA; Pimentel JP; de Paula L; de Almeida CM; Tarragô AM; Tateno A; Levi JE; Teixeira-Carvalho A; Martins-Filho OA; Lira Eda F; Torres KL; Talhari S; Malheiro A
Immunol Lett; 2013; 154(1-2):61-9. PubMed ID: 23973662
[TBL] [Abstract][Full Text] [Related]
19. Association between HCV amino acid substitutions and outcome of peginterferon and ribavirin combination therapy in HCV genotype 1b and high viral load.
Toyoda H; Kumada T; Tada T; Arakawa T; Hayashi K; Honda T; Katano Y; Goto H
J Gastroenterol Hepatol; 2010 Jun; 25(6):1072-8. PubMed ID: 20594221
[TBL] [Abstract][Full Text] [Related]
20. HCV virological response during treatment of chronic hepatitis C is associated with liver histological improvement in patients with HCV/HIV co-infection.
Castro G; Ramalho LN; Zucoloto S; Martinelli Ade L; Figueiredo JF
Braz J Infect Dis; 2008 Jun; 12(3):180-5. PubMed ID: 18833400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
